Evolve Private Wealth LLC Purchases Shares of 9,035 The Cooper Companies, Inc. $COO

Evolve Private Wealth LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, Holdings Channel.com reports. The firm purchased 9,035 shares of the medical device company’s stock, valued at approximately $648,000.

Other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares in the last quarter. First Trust Advisors LP raised its holdings in shares of Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after acquiring an additional 73,165 shares in the last quarter. Cresset Asset Management LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at about $291,000. Cerity Partners LLC boosted its position in shares of Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after acquiring an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its position in shares of Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after acquiring an additional 973 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of several research analyst reports. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research report on Wednesday, May 27th. UBS Group began coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price for the company. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Robert W. Baird decreased their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Finally, Needham & Company LLC lowered their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $75.80 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $14.78 billion, a PE ratio of 64.24, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83. The business’s 50-day moving average price is $72.09 and its 200-day moving average price is $71.07. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.